Alexander Cumbo, SVP, Chief Commercial Officer at Sarepta Therapeutics, Inc. (SRPT), sold 67,564 shares at $137.32 ($9.3M) on 2018-07-09, disclosed to the SEC on 2018-07-11.
Open-market sale of $9.3M SRPT by SVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.32 | 9,944 | $1.4M | 14.7% |
| 2 | $137.32 | 9,944 | $1.4M | 14.7% |
| 3 | $137.32 | 11,914 | $1.6M | 17.6% |
| 4 | $137.32 | 11,914 | $1.6M | 17.6% |
| 5 | $137.32 | 11,924 | $1.6M | 17.6% |
| 6 | $137.32 | 11,924 |
| $1.6M |
| 17.6% |
| Total | $137.32 avg | 67,564 | $9.3M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $517K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $110K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $45K | — | Filing → |